Literature DB >> 1085291

Ocular pathology induced by the suckling mouse cataract agent.

R P Friedlaender, M F Barile, T Kuwabara, H F Clark.   

Abstract

The eye disease caused by SMCA may be best characterized as an endophthalmitis, with early retinitis followed by subsequent posterior uveitis. Pathologic features of lens included: proliferation and abnormal posterior extension of lens epithelium, increased accumulation of lens capsule material, and production of aberrant lens substance. Cataractous change appears to be secondary to intraocular inflammation. In addition to the above pattern, in roughly 20 per cent of all cases, 3 weeks after inoculation, lens capsule is destroyed giving rise to a foreign body granulomatous reaction.

Entities:  

Mesh:

Year:  1976        PMID: 1085291

Source DB:  PubMed          Journal:  Invest Ophthalmol        ISSN: 0020-9988


  5 in total

1.  Pathogenicity of Spiroplasma sp. strain SMCA in Syrian hamsters: clinical, microbiological, and histological aspects.

Authors:  H Kirchhoff; T Kuwabara; M F Barile
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

2.  Characterization of Spiroplasma mirum (suckling mouse cataract agent) in a rabbit lens cell culture.

Authors:  F Megraud; L B Gamon; G J McGarrity
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

3.  Pathogenicity of Spiroplasma sp. strain SMCA in rabbits: clinical, microbiological, and histological aspects.

Authors:  H Kirchhoff; J Heitmann; G Trautwein
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

Review 4.  Characterization and taxonomic status of tick spiroplasmas: a review.

Authors:  J G Tully; R F Whitcomb; D L Rose; D L Williamson; J M Bové
Journal:  Yale J Biol Med       Date:  1983 Sep-Dec

5.  Ocular Spiroplasma ixodetis in Newborns, France.

Authors:  Alexandre Matet; Anne Le Flèche-Matéos; François Doz; Pascal Dureau; Nathalie Cassoux
Journal:  Emerg Infect Dis       Date:  2020-02-17       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.